12:00 AM
 | 
Sep 13, 1999
 |  BC Week In Review  |  Company News  |  Deals

Albany Molecular Research, EnzyMed Inc. deal

AMRI, a chemistry outsourcing company, will acquire EnzyMed, which markets its combinatorial biocatalysis platform for drug discovery applications,...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >